This bill increases statutory punishments for federal health care fraud. It raises the maximum prison term under 18 U.S.C. §1347 and substantially increases fines and prison terms under 42 U.S.C. §1128B, while directing the U.S. Sentencing Commission to review (and, if appropriate, amend) sentencing guidelines for those offenses.
Those changes are forward‑looking: the new statutory maximums and monetary amounts apply only to conduct on or after enactment. For compliance officers, health‑system counsel, and defense counsel, the bill raises the potential downside of enforcement, increases prosecutorial leverage in plea bargaining, and signals that sentencing policy should treat certain aggravating factors — including unauthorized disclosure of personal health information and threats to public health — as hooks for harsher punishment.
At a Glance
What It Does
The bill amends 18 U.S.C. §1347 (health care fraud) to raise statutory maximum prison terms and amends 42 U.S.C. §1128B (criminal penalties for acts involving Federal health care programs) to raise fines and maximum prison terms. It also instructs the U.S. Sentencing Commission to review and, if appropriate, revise its guidelines and policy statements for these offenses, listing aggravating and mitigating factors to consider.
Who It Affects
Federal prosecutors, defense attorneys, health care providers and executives who bill federal programs (Medicare/Medicaid), compliance departments, and the U.S. Sentencing Commission are directly affected. Indirectly, health plans, contractors, and vendors whose conduct touches federal health programs will face greater enforcement risk and potential civil/criminal exposure.
Why It Matters
By increasing statutory maximums and directing guideline revisions, the bill raises the practical cost of a fraud conviction — changing charging incentives and plea dynamics without altering the elements of the underlying offenses. Compliance and risk teams must reassess exposure, and courts and corrections officials should expect pressure on sentencing and incarceration resources.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core change in this bill is straightforward: it makes the criminal penalties for health care fraud significantly stiffer. For the primary federal health‑care fraud statute (18 U.S.C. §1347), the bill increases the statutory maximum prison term for ordinary health care fraud and for fraud that results in serious bodily injury or death.
For offenses tied to federal health programs under 42 U.S.C. §1128B, the bill raises the dollar amounts attached to criminal fines and increases maximum prison terms for covered conduct and misrepresentations.
Beyond raw statutory penalties, the bill requires the U.S. Sentencing Commission to review existing sentencing guidelines for these offenses and to consider a specific list of aggravating and mitigating circumstances. The Commission must account for loss (including qualitative harms to victims), sophistication, commercial purpose, intent to cause harm, unauthorized disclosure of personal health information, threats to public health or safety, and the defendant’s role and duration of misconduct.
The Commission is also instructed to make any necessary conforming changes so guideline ranges reflect these concerns and the purposes of sentencing under 18 U.S.C. §3553(a)(2).Practically, the amendments are prospective: the changes to §1347 apply to conduct on or after enactment, and the §1128B changes apply to acts and statements made on or after enactment. Prosecutors therefore gain higher statutory ceilings for charging and negotiation, but courts retain discretion and the Sentencing Commission retains a rule‑making role for guideline adjustments.
For regulated entities, the combination of higher fines, longer potential sentences, and an emphasis on harms such as PHI disclosure and public‑health threats signals tougher enforcement priorities and requires recalibration of compliance, documentation, and billing controls.
The Five Things You Need to Know
The bill raises the maximum prison term under 18 U.S.C. §1347 from 10 years to 25 years for ordinary health‑care fraud and from 20 years to 30 years where the offense results in serious bodily injury or death.
It amends 42 U.S.C. §1128B to increase statutory fines from $100,000 to $250,000 and raises maximum imprisonment terms in that provision from 10 years to 25 years.
Section 3 makes three additional numeric changes to §1128B: it increases a specified penalty in subsection (a) from $20,000 to $100,000, raises a separate per‑violation amount in subsection (e) from $4,000 to $100,000, and lengthens a misdemeanor maximum jail term in subsection (e) from six months to one year.
The bill directs the U.S. Sentencing Commission (under 28 U.S.C. §994(p)) to review and, if appropriate, amend sentencing guidelines and policy statements for the covered offenses and to consider listed aggravating factors including unauthorized disclosure of personal health information and threats to public health.
All statutory changes are prospective: amendments to §1347 apply to conduct on or after enactment and amendments to §1128B apply to acts, statements, or conduct on or after enactment.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s short title: the 'Punishing Health Care Fraudsters Act.' This is a formal designation only and has no operative effect on enforcement or interpretation of the substantive amendments that follow.
Amendments to 18 U.S.C. §1347 (health care fraud)
This section replaces the statutory imprisonment caps that currently appear in the preface to subsection (b) of §1347: the bill changes the ordinary maximum from 10 to 25 years and the aggravated maximum (where serious bodily injury or death results) from 20 to 30 years. The provision explicitly limits the change to conduct occurring on or after enactment, so prosecutions for earlier conduct will proceed under the prior statutory ceilings. For practitioners, the mechanics are simple but consequential: higher statutory maxima increase potential exposure and bargaining leverage for prosecutors even though the elements of the offense are unchanged.
Amendments to 42 U.S.C. §1128B (criminal penalties for acts involving Federal health care programs)
This section implements multiple numeric increases in §1128B. It raises several monetary penalties (the statutory $100,000 fine becomes $250,000; a separate $20,000 amount in subsection (a) becomes $100,000; and a per‑violation amount in subsection (e) goes from $4,000 to $100,000) and lengthens certain statutory incarceration limits from 10 to 25 years and from six months to one year where specified. Like Section 2, these changes are prospective and apply to acts and statements on or after enactment. The practical effect is to upgrade both the criminal and monetary stakes tied directly to conduct involving federal health programs, widening the range of potential sanctions prosecutors can seek.
Sentencing Commission review and required considerations
This section defines 'covered offenses' to include §1347 and §1128B offenses and directs the U.S. Sentencing Commission to review its guidelines and policy statements for those offenses under 28 U.S.C. §994(p). The statute lists specific factors the Commission must consider (loss, sophistication, commercial purpose, intent to cause harm, unauthorized PHI disclosure, public‑health threats, role and duration) and requires the Commission to ensure guideline ranges reflect seriousness, consistency with other directives, and the statutory purposes of sentencing. The provision does not mandate particular guideline ranges or numerical increases, but it constrains the Commission’s review by identifying the policy vectors it must address and authorizes conforming changes to other guidelines as necessary.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Federal prosecutors and law enforcement — The statute raises statutory ceilings and fine amounts, increasing charging leverage and potential sentencing exposure, which prosecutors can use in negotiations and deterrence messaging.
- Federal health programs (Medicare, Medicaid, and related trust funds) — Higher fines and longer potential sentences expand the range of remedies available when providers or vendors defraud or harm federal programs, increasing potential recovery leverage and deterrence against large‑scale fraud schemes.
- Patients and public‑health advocates — By singling out harms such as unauthorized PHI disclosure and threats to public health as aggravating factors, the bill prioritizes protection of patient privacy and public‑health integrity in sentencing considerations.
Who Bears the Cost
- Health care providers and executives (including small practices and contractors) — Higher fines and longer prison exposure raise compliance risk and potential personal liability for officers or clinicians implicated in billing schemes or misconduct.
- Defense counsel and indigent defense systems — Larger statutory maxima can increase case complexity, lengthen litigation, and raise defense costs; public defenders and court systems may face higher resource demands.
- Federal courts, Bureau of Prisons, and Sentencing Commission — If prosecutions lead to longer sentences, courts and corrections systems incur greater caseload, imprisonment, and administrative burdens; the Sentencing Commission must allocate resources for the mandated review and possible rule amendments.
Key Issues
The Core Tension
The bill pits deterrence and accountability against proportionality and system capacity: it seeks to deter and punish serious fraud by raising statutory maximums and highlighting aggravating conduct (like PHI disclosure and threats to public health), but higher ceilings risk overcriminalizing billing errors, increase prosecutorial leverage in ways that may produce harsher outcomes for lesser offenders, and place additional burdens on courts, defenders, and corrections without remedying the underlying resource and discretion questions.
The bill heightens penalties but leaves crucial discretion untouched — it raises ceilings rather than changing elements of proof or burdens. That raises two implementation challenges.
First, statutory maximums affect prosecutorial leverage far more than actual sentence outcomes, because most federal cases resolve by plea and judges often sentence below the statutory maximum; without commensurate guideline increases, the practical effect on average sentences may be modest. Second, the numeric increases and the specified aggravating factors risk swallowing nuance: higher fines and longer terms that apply where intent is hard to prove could incentivize prosecutors to pursue charges in borderline conduct (administrative errors, unclear documentation) rather than reserving criminal enforcement for clearly culpable fraud.
There are also system‑level tradeoffs. Increasing maximum sentences and fines without providing additional resources for courts, defenders, and corrections shifts costs downstream and could produce proportionality concerns in sentencing.
The Sentencing Commission is required to consider specific factors (including unauthorized PHI disclosure and public‑health threats), but the statute does not prescribe how those factors convert into offense levels or adjustments; that leaves substantial discretion to the Commission and judges and raises the possibility of uneven application across districts. Finally, the prospect of much larger fines may push small providers into insolvency rather than rehabilitation, with secondary impacts on access to care and contract markets.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.